Effects of a Lower Limb Strength Training Program on a Seated Robotic Device in Patients
NCT ID: NCT05020171
Last Updated: 2024-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
5 participants
INTERVENTIONAL
2021-09-20
2024-01-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Locomotion Training With Assistance of a Robot-Driven Gait Orthosis in Hemiparetic Patients After Subacute Stroke
NCT01726998
Therapeutic Effects of Robotic Exoskeleton-Assisted Gait Re-habilitation and Predictive Factors of Significant Improvements in Stroke Patients
NCT05825144
The Effectiveness of Exoskeleton Type Robotic Gait Training Using CIMT for Lower Extremity: in the Aspect of Gait Independence and Balance
NCT04649684
Impact of Hip Flexors Isokinetic Strengthening on Gait Capacities in Subacute Stroke Patients
NCT02917850
Effects of Backward Gait Training With Exoskeleton on Motor Functions
NCT05133362
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
group focus on lower limb strength training with a seated robotic device
Group of strength training
2x a week during 5 weeks, strengthening of weak muscles with the intensity recommended in the literature, i.e. 3-4x15 repetition at an intensity of 50 to 80% of the maximum force combined with serious games to stimulate patient involvement in strength training
control group
physiotherapy group as usual, not focused on strength training
Group of physiotherapy not focus on strength training
2x a week during 5 weeks, active physical therapy treatment based on movement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group of strength training
2x a week during 5 weeks, strengthening of weak muscles with the intensity recommended in the literature, i.e. 3-4x15 repetition at an intensity of 50 to 80% of the maximum force combined with serious games to stimulate patient involvement in strength training
Group of physiotherapy not focus on strength training
2x a week during 5 weeks, active physical therapy treatment based on movement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Walking ability ≤ Functional Ambulatory Category level 5 (1-6)
* Paresis of the lower limb: strength \<57/100 on the Motricity Index
* Cognitive and memory functions allowing the patient to follow treatment instructions and give informed consent
Exclusion Criteria
* Venous thrombosis less than 6 months
* Musculoskeletal impairment not compatible with movement
* Degenerative neurological disease
* Oxygen-dependent
* Blood pressure not stabilized
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institution de Lavigny
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claude Pichonnaz, PhD
Role: PRINCIPAL_INVESTIGATOR
Haute Ecole de Santé Vaud
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institution de Lavigny
Lavigny, Canton of Vaud, Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-O20
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
2021-00721
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.